Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

7.43
Delayed Data
As of May 23
 -0.05 / -0.67%
Today’s Change
6.15
Today|||52-Week Range
11.34
-17.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-5.7M-7.2M-11.0M-10.5M
 
 
 
 
 
Depreciation6.0K4.0K4.0K5.0K
 
 
 
 
 
Total Other Cash Flow1.5M1.4M572.0K1.8M
 
 
 
 
 
Funds From Operations-4.2M-5.8M-10.4M-8.7M
 
 
 
 
 
Funds From/For Other Operating Expenses-161.0K-862.0K-15.0M-2.9M
 
 
 
 
 
Net Cash Flow - Operating Activities-4.1M-4.9M4.7M-5.8M
 
 
 
 
 
 
InvestingIncrease In Investments-55.8M-1.9M-31.1M-24.7M
 
 
 
 
 
Decrease In Investments42.7M19.7M15.1M29.0M
 
 
 
 
 
Capital Expenditures-14.0K-1.0K-9.0K-7.0K
 
 
 
 
 
Other Investing - Uses-2.0K-21.1M-2.0K-3.0K
 
 
 
 
 
Other Investing - Sources2.0K0.000.000.00
 
 
Net Cash Flow Investing-13.1M-3.3M-16.0M4.3M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale16.6M9.7M12.0M1.6M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing16.6M9.7M12.0M1.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash6.0K-12.0K6.0K5.0K
 
 
 
 
 
 
Net Change In Cash-516.0K1.5M688.0K57.0K